| abstract |
The present invention provides a pharmaceutical composition for use in preventing or treating human rhinovirus (HRV) infection. The composition comprises an aldoxose, in which the hydroxyl group on carbon 2 of the aldoxose is replaced by any one of H, F, Cl, Br, I, SH, Me, OMe and SMe, as a 2-deoxy-glucose. In addition, a dispenser for intranasal administration is provided, such as a nasal spray or nasal drops applicator containing said pharmaceutical composition. In addition, an inhalation device, such as a metered dose inhaler, dry powder inhaler or nebulizer, is provided, comprising said composition. |